A new treatment for adults with insomnia disorder has been recommended for use in Europe, giving hope to people whose lives are blighted by the condition.
The approval of Novavax' COVID-19 vaccine in Great Britain could help the country save a "considerable amount of money" if it is used in future booster campaigns, according to the former ch
The MHRA has kicked off an eight-week consultation on proposals for changes to laws governing the conduct of clinical trials following the UK's departure from the EU.
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved Jyseleca (filgotinib) 200mg tablets to treat ulcerative colitis (UC) in adults whose UC is moderately to severely acti
The UK medicines regulator has approved GlaxoSmithKline and Vir Biotech's antibody for COVID-19, Xevudy, which has been shown to be effective against the new Omicron strain of SARS-CoV-2 in
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.